Bristle has developed a convenient low-cost state-of-the-art salivary test, leveraging next-generation sequencing of the oral microbiome, which can inform on the risk of periodontal disease and dental caries.Read more
Bristle announces the closing of their $3m seed round today, led by Initialized Capital, with investments from Y Combinator and Anne Wojcicki (CEO, 23andMe). Bristle helps people measure, understand, and improve oral health through the oral microbiome.Read more
Choosing a selection results in a full page refresh.
